# N4 Pharma Chengzhong Yu awarded grant to work on patented nuvec® nanoparticle

- Link: https://www.directorstalkinterviews.com/n4-pharma-chengzhong-yu-awarded-grant-to-work-on-patented-nuvec%c2%ae-nanoparticle/4121122748
- Published: 2023-06-27T07:12:24+01:00
- Author: Ethan Davis

N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec
®, a novel delivery system for cancer treatments and vaccines, is pleased to announce
it will be supporting the University of Queensland as part of a recent grant award
by the Australian Research Council.

The University of Queensland has announced that Professor Chengzhong Yu, Senior 
Group Leader, Australian Institute for Bioengineering and Nanotechnology (AIBN) 
has been awarded a $402,115 grant to develop an improved nanoparticle delivery system
that enhances the performance of messenger ribonucleic acid (mRNA) therapies. The
new nanoparticle will be based on the Company’s patented nuvec® nanoparticle that
it has licensed exclusively from the University of Queensland.

N4 Pharma will work with Professor Yu to tackle the current challenges in manufacturing
mRNA therapeutics, by building new knowledge in custom-design of functional nanomaterials
for mRNA delivery. mRNA is a highly lucrative field of therapeutic science and is
emerging as a major drug platform.

> “We will be working on new technology that brings clear commercial benefits, not
> just for our industry partner, but the wider mRNA industry and biopharma sector,”**
> Professor Yu said.**

> **Nigel Theobald, Chief Executive Officer of the Company, commented:**
> “We are pleased to continue our close collaboration with Professor Yu and work
> on new ways to build on the performance of our Nuvec® nanoparticle together.”

Share on:
